1. Twenty-six sheep were used in experiments designed to test the effectiveness of ammonium tetrathiomolybdate in the prevention and treatment of chronic copper poisoning.
Mo in tissues. Mo was estimated by a modification of the method described by Norheim & Waasjo (1977) on the, liver and kidney of all sheep in Expt 2.
Preparation of TM. TM was prepared by bubbling hydrogen sulphide gas through a solution of ammonium molybdate as described by Tridot & Bernard (1962) . Crystals of TM harvested were disscdved in sterile saline (9 g sodium chloride/l) as a 50 mg/ml solution and stored as 5 or 10 ml portions in stoppered sterile vials at -2OO. When required, the solutions were thawed at room temperature, centrifuged and the supernatant fraction was used for intravenous administration. Tetrathiomolybdate was identified as the predominant component from the absorption spectra (Aymonino et al. 1969 ) with peaks at 241,316 and 463 nm. After storing the TM for the duration of the experiment (4.5 months) there was no change in the absorption spectrum other than a decrease of approximately 3% in the molar extinction.
Histology. Sections for light microscopy were prepared from liver, kidney, spleen and femur. These tissues were fixed in buffered formal saline, embedded in paraffin wax and 5 ,um sections stained by haeniatoxylin and eosin. Liver and kidney sections were stained by the periodic acid Schiff (PAS) method with and without diastase (EC 3.2.1 . l), and by the rubeanic acid and 5-p-climethylaminobenzylidine rhodanine (DMABR) methods for Cu. Kidney sections were also stained with Perls' Prussian blue method for Fe.
RESULTS

Clinical Findings
The details of individual sheep are given in Tables 1 and 2 .
Expt I
Sheep in group A received three dosages of TM (Table I) for varying periods of time and were killed at different intervals of time to assess the sequence of changes occurring in a variety of tissues. Nonr: of the sheep in group A had a haemolytic crisis and were killed after all the sheep in group B went into haemolysis. All sheep in group A except no. 214 remained clinically normal throughout the experiment. Sheep no. 214 became anorexic after receiving the second injection of the higher dose (4 ml) of TM, passed soft faeces, had pale conjunctiva but was nc t jaundiced. This animal was killed in extremis.
Abnormalities were not seen in any of the sheep in group B before the onset of haemolysis. Signs of haemolysis were similar to those previously reported (Todd, 1962) . One animal died at haemolysis before receiving its first TM injection and will not be considered further here. Of the remaining three sheep, two which received 2 ml doses of TM, developed watery diarrhoea after two injtztions. The diarrhoea persisted, one sheep died and the other was killed in extremis. The m l y animal to survive in this group received 1 ml dose of TM, did not develop diarrhoea and was killed after four injections of TM.
Expt 2
The sheep in this experiment did not develop diarrhoea. Sheep in groups 3 and 4 did not show any clinical abnormality throughout the course of the experiment. Abnormalities were not seen in any of the sheep in other groups before the onset of haemolysis. The signs seen at haemolysis were similar to those seen in Expt 1. Loss in body-weight occurred in sheep in groups 1A and 2A that died at haemolysis, while animals in groups 3 and 4 increased in body-weight. Of the six sheep given TM at haemolysis (group 2), two died after one injection and the :-emaining four survived from 77-79 d following haemolysis when they were killed in good health. This result should be compared with a mortality of three of four sheep not given TM at haemolysis (group 1). 
Postmortem findings Expt 1
Abnormalities were not seen in any of the sheep in group A except for sheep no. 214 which was killed in extremis. The liver of this animal was swollen and bronze coloured and its kidneys were swollen and had petechial haemorrhages. Of the sheep in group B, abnormalities were not seen in organs of sheep no. 219 but sheep nos. 217 and 218 were severely dehydrated, had pale, swollen livers and dark swollen kidneys, changes that are typical of chronic Cu poisoning (Gopinath & Howell, 1975) .
Expt 2 Groups 1 A and 2 A . The changes seen in these animals were typical of those seen in sheep that were killed or had died during the haemolytic crisis of chronic Cu poisoning (Gopinath & Howell, 1975) .
Group 1B. The livers of sheep in this group were dark yellow in colour. This was most marked in one sheep which also had mottled, greyish black kidneys and pneumonic lungs.
Group 2B. The livers of these animals were darker than normal. This was most marked in two sheep which also had very dark brown kidneys.
Group 3. The livers were of normal colour but were friable and the kidneys were blackish brown in colour.
Group 4 . Gross abnormalities were not seen in livers and kidneys of sheep in this group.
Histology Expt 1. Liver and kidney
Group A . Numerous large pigmented Kupffer cells were scattered throughout the lobules. They were PAS positive and stained for Cu with rubeanic acid and DMABR. The cells around the central vein were not necrotic but a few necrotic hepatocytes were present within some lobules. Kidneys showed a marked increase in brown or eosinophilic granules within the cytoplasm of tubule cells. These granules did not stain positively for Fe but some of them gave a positive reaction with the Cu stains. The tubules of sheep nos. 214 and 215 were dilated.
Group B. The changes in the liver were similar to those in Group A. The kidney tubules of all sheep were dilated, contained casts and had heavily-pigmented deposits within them. l'his pigment gave a positive reaction for Fe with Perls' stain but did not stain for Cu.
Expt 1. Spleen
Significant alterations were not observed except for the presence of brown, Fe containing, pigmented macrophages in sheep of Group B.
Expt 2. Liver
The changes seen in livers of sheep in groups 1A and 2A were typical of those seen in sheep at the time of the haemolytic crisis of chronic Cu poisoning in that numerous large pigmented Kupffer cells were present and many centrilobular parenchymal cells were necrotic (Gopinath & Howell, 1975) .
The livers of the two sheep in group 1B contained numerous large pigmented Cu containing Kupffer cells and some necrotic parenchymal cells. The changes were similar to those reported in animals killed in the post-haemolytic phase of chronic Cu poisoning (Gopinath & Howell, 1975) . The livers of sheep in group 2B showed little evidence of damage. Centrilobular necrosis was absent but a few isolated necrotic parenchymal cells were seen, and small numbers of large Kupffer cells with reddish or yellow cytoplasm which stained for Cu were found scattered throughout the lobule.
Livers of group 3 sheep were similar to those seen in group 2B except that fewer necrotic Changes within the livers of group 4 sheep were minimal, the only change observed was cells were found within the lobules.
the presence of a small number of large Kupffer cells with red or brown cytoplasm.
Kidney
The changes observed in the kidneys of sheep in groups 1 A and 2A were typical of those seen in sheep that died or were killed during the haemolytic crisis (Gopinath et al. 1974) , in that there was exten!;ive necrosis and degeneration of tubule cells. Many tubule cells contained pigment granules which were positive for Fe. The changes seen in group 1 B sheep were similar but necrosis was not widespread. The histological appearance of the kidneys of sheep in groups 2B and 3 was similar in that little damage was evident. Some tubule cells contained cytoplasmic granules which gave a positive reaction for Cu. Changes in the kidneys of sheep in group 4 were minimal.
Femur
The femurs of sheep in groups 1 A, 1 B, 2A and of two sheep in group 3 showed little activity in the endochondral plate much of which was sealed off. In the remaining sheep the endochondral plate was still active.
Tissue Cu levels Expt. 1. The Cu levels in liver, kidney, left ventricle and spleen of individual sheep together with the total amount of Cu and TM administered to each sheep is given in Table 1 . In group A, although sheep nos. 213 and 215 were dosed with approximately the same amount of Cu, sheep no. 21 5 received more TM and had a much lower Cu level in its liver. A similar pattern was observed be1 ween sheep nos. 2 17 and 21 8 of group B. The kidneys of all sheep had high Cu levels.
Expt 2. The Cu levels in liver and kidney of all sheep are given in Table 2 . Liver Cu levels of sheep in groups 1 A, 1B and 2A were markedly increased when compared with the levels of those sheep in other groups which received more than one TM injection. Even though all sheep in group 3 were dosed with Cu for more than 110 d and hence received the highest amount of Cu, the amount of Cu stored in their livers was much less than that found in the livers of sheep in groups 1 A and 2A which were dosed only for 80 and 66 d respectively. However, the kidneys of sheep in group 3 accumulated large amounts of Cu. The sheep in group 4 had low liver Cu levels but the Cu levels in their kidneys was more than would be found in the kidneys of normal sheep 15.55 k0.96 (Gopinath et al. 1974); 15.05+0.38 (Gooneratne, 1979) .
Tissue Zn and Fe Levels
Expt I . Iron levels in liva and left ventricle of all sheep and spleen and kidneys of sheep in group A were within the normal range (Table l) , but the spleen and kidneys of sheep in group B had markedly elevated Fe levels. Expt 2. The sheep in groups 1A and 2A that died at haemolysis, and those in group 1 B that had haemolytic crisis but did not receive TM, had markedly elevated Zn (265-8 +49-4 pg/g liver DM) and Fe levels in their livers and increased Fe levels in their kidneys. Values for Fe ar: given in Table 2 . Zinc (1 20-7 & 5.4 pg/g liver DM) and Fe levels were low in livers of sheep which received TM and survived (groups 2B, 3 and 4). Zn levels in the kidneys of these tkree groups of sheep were variable (1 15.4k5.8 pg/g kidney DM) but the Fe levels were low.
Tissue Mo levels Mean levels of Mo in liver and kidneys of all groups of sheep of Expt 2 are given in Table  2 . The sheep in groups 1A and 1B which did not receive TM had low Mo levels in their livers and kidneys. The mean Mo levels in the livers and kidneys of two sheep in group 2A were 23 and 38 pg/g DM respectively after one injection of TM. Sheep in groups 2B and 3 had high Mo levels in both liver and kidney and this was most marked in sheep of group 3 which received Cu continuously along with TM injections. Although the sheep in group 4 received the same dose of TM as those in group 2B, the Mo levels in the liver and kidneys of the sheep in group 4 were much lower.
SD activity All sheep dosed with CuSO, solution had high levels of SD activity in plasma before haemolysis, including those that received TM in addition to Cu (group A, Expt 1 ; group 3, Expt 2). Peaks of SD activity were not observed in any animal after the cessation of haemolysis and at no time was SD activity elevated in animals given TM but not Cu (group 4, Expt 2).
D I S C U S S I O N
Dietary supplements of Mo and SO, have previously been used in attempts to prevent the occurrence of chronic Cu poisoning in sheep (Ross, 1966; Hogan et al. 1968; Kline et al. 1971; Suttle, 1979) . The results presented here show for the first time that chronic Cu poisoning can be prevented by the intravenous administration of TM, a compound that contains Mo and S, and that has been postulated to form in the rumen of sheep fed supplements of Mo and SO, (Dick et al. 1975) .
The main aim of Expt 1 was to determine the amounts of TM to be used in sheep of different Cu status. It was found that dose rates of 100 mg TM twice weekly, or 50 mg TM twice weekly were safe for animals receiving Cu or not receiving Cu, respectively. When these doses were increased diarrhoea occurred. Molybdenumcontaining supplements have been previously observed to cause diarrhoea in ruminants (Allcroft & Lewis, 1956; Ward, 1978) and Fell et al. (1979) reported lesions in the enterocytes of rats given TM. The mechanism of these effects is still uncertain. Some workers have noted that Mo is largely excreted in the faeces of ruminants (Bell et al. 1964; Miller et al. 1972) and that it may disturb bacterial activity in the large intestine and thereby cause diarrhoea (Underwood, 1976) . Others have postulated that because molybdate depresses liver sulphide oxidase (EC 1 . 8 .3.1) activity, the diarrhoea may result from a failure to oxidize highly toxic endogenous sulphide. Oral Cu supplements can prevent the diarrhoea caused by Mo (Brouwer et al. 1938; Ferguson et a1 1938 Ferguson et a1 , 1943 . Thus, in our experiments animals receiving Cu were able to tolerate twice the TM dose of animals not receiving oral Cu. It appears that even when TM is given intravenously it exerts an effect on the alimentary canal possibly because it is excreted into the gut contents. The prevention of diarrhoea by dietary Cu under these circumstances is consistent with the hypothesis of Dick et al. (1975) in which TM combines with Cu in the gut to form an insoluble and therefore non-toxic compound.
The intravenous injections of TM decreased the concentration of Cu in the liver (Table 2) . Thus, TM at a dose rate of 50 mg twice weekly for 11 weeks caused a decrease of 1797pg
Cu/g liver (3 122-1 325 pug) a decrease of approximately 58 % of the liver copper. Expressed in another way, 1 mg atom Mo caused a decrease of about 0.5 mg atom Cu from the liver. (This calculation is based on average liver dry weight of 121 g). Similarly, TM injections reduced liver Cu levels in animals not receiving supplemental Cu (Expt 2, group 4). In these
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animals the liver Cu concentration was 96 pglg, compared with levels of 258 pg/g in normal sheep on a similar diet (Gooneratne et al. 1979) . The sheep given this treatment may have been marginally Cu deficient, since caeruloplasmin oxidase activity was beginning to decrease in the later stages of the experiment (Gooneratne, 1979) .
According to Suttle (1979) TM given in the food to postweaned sheep reduces only the absorbability of Cu from Ihe gut and does not greatly accelerate the removal of Cu already accumulated in the liver, but the levels of TM fed in that experiment were low (3 mg Mo/kg DM of pelleted food) and ~t is possible that all the TM complexed with Cu within the gut, leaving none to complex with the Cu in the liver. The decrease in liver Cu in the present experiment occurred even in the presence of a high level of plasma Cu and with a direct-reacting Cu level that increased with each TM injection (Gooneratne el al. 1981) .
As expected, the Mo levels in liver and kidney of sheep injected with TM were high. In Expt 2 the sheep in grours 2B and 4 were injected with the same amount of TM but the liver Mo levels of group 2B sheep were more than five times and their kidney levels more than twice, the levels of shzep in group 4. Sheep in group 3 which received the higher doses of TM (2 ml), had liver M o levels which were no more than twice those found in livers of sheep in group 2B while t i e kidneys contained more than four times the Mo levels found in kidneys of sheep in group 2B. Thus it appears that the deposition of Mo in liver and kidney depends on the availability of Cu within the body. Availability of Cu could be exogenous as in group 3 or endogenous as in sheep of group 2B which had stored Cu in their liver before the start of TM injections. It is possible that Mo present in these organs was being deposited as a Cu-Mo complex. Similar observation on the accumulation of Cu in the kidneys of Mo-supAemented sheep have been reported by Smith et al. (1968) and Marcilese et al. (1970) . Bremner & Young (1978) reported that Cu and Mo accumulated together in the kidneys of Mo and SO, fed sheep in the ratio of about 2 : 1. This was clearly not so in the present experiment where much higher levels of Mo and S were injected as TM.
The presence of increascd Zn and Fe levels in livers containing high Cu levels are similar to our previous findings (Gooneratne et al. 1979) . Sheep which died at haemolysis had large amounts of Fe in their Lidneys. This is probably due to increased amounts of Fe, as breakdown products of erythrocytes being deposited in the kidneys. The presence of large amounts of Fe in the spleens of sheep that had undergone a haemolytic crisis (group B of Expt 1) was probably duz to the phagocytosis of the breakdown products of damaged erythrocytes by the reticulo-endothelial system (Schalm et al. 1975) . It was interesting to find comparatively low Fe levels in the kidneys of sheep given TM and possibly TM may have been responsible for its removal. This property of TM could yet be another factor responsible for the rapid recovery from haemolysis and the small amount of kidney damage found in treated sheep.
The administration of TM did not appear to produce histologically-detectable damage to liver or kidney even though both tissues contained high levels of Mo and the kidneys contained more than the normal amounts of Cu. These animals increased in weight throughout the course of the experiment. Although high SD levels were observed in the plasma of sheep in group 4 of Expt 1 and in group 3 of Expt 2 there was little histological evidence of liver damage. There was also little evidence of morphological or functional kidney damage despite the high level of Cu present. This result confirms the findings of Gopinath et al. (1974) wh3 were of the opinion that both hypercupraemia and haemolysis were required to produce the kidney damage seen in chronic Cu poisoning. These results indicate that TM prolonged the pre-haemolytic phase of chronic Cu poisoning, prevented the development of extensive centrilobular necrosis of the liver and the development of haemolytic anaemia. It is possible that lowering the excessive Cu deposition in the livers of sheep in group 3 of Expt 2, may have prevented damage to the liver and this may possibly have been a key factor in the prevention of haemolysis. The four sheep which were given TM at haemolysis and subsequently killed (group 2B of Expt 2) showed little evidence of centrilobular necrosis of liver or of kidney damage. Yet these animals had developed a haemolytic crisis. The tissue recovery was probably a direct result of TM treatment and is worthy of further investigation.
Although connective tissue changes in long bones of sheep grazing high-Mo pastures (Underwood, 1976) and skeletal abnormalities in rats given TM in the diet (Spence et al. 1980) have been reported, such changes were absent in the femurs of sheep given TM injections. The only change seen in the femurs was closure of the endochondral plate in sheep that developed a haemolytic crisis and which did not receive or were given a small amount of TM, and in two animals given TM at the second rise of SD.
It may be concluded from the present study that TM injections prevented: (a) the Occurrence of the haemolytic crisis when given to sheep before haemolysis and (6) the occurrence of further ' haemolytic crises' and the development of significant tissue damage when given to sheep already in haemolysis. Gopinath & Howell (1975) showed that cessation of Cu dosing alone does not necessarily lead to quick elimination of Cu from the tissues. They thought that persistently-elevated levels of Cu in liver parenchymal cells may affect the structure and function of the cells which may then contribute to further crises. Thus the metabolic role of TM in chronic Cu poisoning appears to be its ability to prevent excessive deposition of Cu in the liver of sheep receiving large amounts of Cu in the diet and its ability to decrease liver Cu levels in sheep receiving normal levels of Cu via the gut. Evalutation of the effects of TM on the histological features of liver, kidney and femur indicated that TM does not cause any undesirable structural defects or any harmful effects on the animal per se, if given in appropriate doses. The tolerated dose would vary and would depend on the Cu status of the animal and its daily intake of Cu. The investigation of the use of this compound for the prevention and treatment of chronic Cu poisoning in sheep will be continued. Further results may suggest its use as an adjunct to penicillamine in the treatment of Wilson's disease in man where it may be of particular value as a short term treatment in cases presenting with haemolysis or with penicillamine associated immune mediated diseases.
